Section Arrow
SRZN.NASDAQ
- Surrozen
Quotes are at least 15-min delayed:2026/07/25 09:53 EDT
Regular Hours
Last
 19.73
-1.43 (-6.76%)
Day High 
21.39 
Prev. Close
21.16 
1-M High
26.825 
Volume 
184.25K 
Bid
18
Ask
32.12
Day Low
19.62 
Open
21.2 
1-M Low
19.985 
Market Cap 
245.68M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 22.04 
20-SMA 23.27 
50-SMA 24.36 
52-W High 35 
52-W Low 8.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-36.59/-3.53
Enterprise Value
251.02M
Balance Sheet
Book Value Per Share
-23.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.48M
Operating Revenue Per Share
1.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OTLKOutlook Therapeutics1.405+0.085+6.44%-- 
CLDICalidi Biotherapeutics0.1-0.005-4.76%-- 
MTNBMatinas Biopharma Holdings Inc0.2414-0.0078-3.13%-- 
RXRXRecursion Pharmaceuticals2.96-0.05-1.66%-- 
SPROSpero Therapeutics1.19+0.03+2.59%4.3PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.